PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEPATIC FIBROSIS AND CIRRHOSIS CONTAINING RAMALIN

摘要

The present invention relates to a novel use of Ramalin for preventing or treating liver diseases, and more specifically, to: a pharmaceutical composition for preventing or treating hepatic fibrosis or cirrhosis containing Ramalin or a pharmaceutically acceptable salt thereof; and a functional food containing same. According to the present invention, Ramalin, which is a compound derived from Ramalina terebrata, is known to remarkably inhibit hepatic fibrosis and to lower cirrhosis levels compared with Silymarin, which is known as a liver cell protecting ingredient, when applied to an animal model, without the cytotoxicity of normal liver cells, and thus can be effectively used for preventing or treating hepatic fibrosis and cirrhosis.